摘要
目的探讨超声造影在肿瘤射频消融治疗（RFA）中的价值。方法选择2012年1月—2013年9月青岛市中心医院收治的53例原发性肝癌患者为观察组,2011年1月—2012年8月收治的48例原发性肝癌患者为对照组,观察组在超声造影指导下,对照组在普通超声引导下行RFA术。结果观察组53例中,表现为动脉期高增强的比例超声造影为81.13%,增强CT/MRI为77.36%（P〉0.05）。术后1个月,病灶稳定/完全灭活率观察组（83.02%）高于对照组（60.38%）（P〈0.05）;肿瘤原位复发率观察组（7.55%）低于对照组（20.75%）（P〈0.05）。随访3∽12个月,观察组无疾病进展的比例为73.58%,对照组为49.06%（P〈0.05）。结论超声造影术中显影良好,不仅指导RFA手术,还可减少肿瘤局部存活率,减少并发症。
Objective To investigate the value of contrast enhanced ultrasound（ CEUS） in Qualitative and Radiofrequency Ablation Therapy in Liver Tumor. Methods Totally 53 cases with liver tumor was the contrast group from January2012 to September,2013,48 cases was the others from January 2011 to August,2013,contrast group received RFA under Contrast- enhanced UItrasound,the others received RFA under UItrasound. Results The enhanced rates of artery period was no significantly in CEUS（ 81. 13%） and CT / MRI（ 77. 36%）（ P〈0. 05）,The rates of Stabled or Inactivated Lesions of the contrast group（ 83. 02%） was significantly higher than the others（ 60. 38%）（ P〈0. 05）,and the reoccurrence rate of the contrast group（ 7. 55%） was lower than the others（ 20. 75%）（ P〈0. 05）. The progression- free survival rates for the contrast group（ 73. 58%） as significantly higher than the others（ 49. 06%）（ P〈0. 05）. Conclusion It is feasible to ablate liver metastatic tumor using RFA under CEUS guidance and recurrence surial rate of tumor,and recurrence complication rates.
出处
《医药论坛杂志》
2015年第2期20-21,共2页
Journal of Medical Forum
关键词
超声造影
肿瘤
射频消融治疗
Ultrasound imaging
Tumor
Qualitative and radiofrequency ablation therapy
